In a number of studies it was demonstrated that Cblb−/− mice can reject tumors in a T cell-dependent fashion, and the adoptive transfer of Cblb-deficient or Cblb-silenced CD8+ T cells together with a dendritic cell vaccine can significantly delay tumor growth and enhance survival rates [34–38]. The gene discussed is CBLB; the disease is neoplasm.